Darin Lippoldt, Chief Legal Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 50,226 shares at $114.05 ($5.8M) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Seasonal sale ($5.8M) by Chief Legal Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.05 | 605 | $69K | 1.2% |
| 2 | $114.05 | 605 | $69K | 1.2% |
| 3 | $116.69 | 687 | $80K | 1.4% |
| 4 | $116.69 | 687 | $80K | 1.4% |
| 5 | $116.72 | 1,522 | $178K | 3.0% |
| 6 | $116.72 | 1,522 |
| $178K |
| 3.0% |
| 7 | $116.74 | 1,198 | $140K | 2.4% |
| 8 | $116.74 | 1,198 | $140K | 2.4% |
| 9 | $116.16 | 30,000 | $3.5M | 59.7% |
| 10 | $116.21 | 6,008 | $698K | 12.0% |
| 11 | $116.21 | 6,008 | $698K | 12.0% |
| 12 | $117.55 | 186 | $22K | 0.4% |
| Total | $116.20 avg | 50,226 | $5.8M | 100% |
| Filing → |
| NBIX | SELL | 2025-12-10 | $1.4M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $510K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $215K | — | Filing → |